​

Medline (MDLN) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

MDLN Stock Forecast

Medline (MDLN) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $48.91, with a high of $60.00 and a low of $38.00. This represents a 32.91% increase from the last price of $36.80.

MDLN Stock Rating

Medline stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (83.33%), 2 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 2 10 0 Strong Sell Sell Hold Buy Strong Buy

MDLN Price Target Upside V Benchmarks

TypeNameUpside
StockMedline32.91%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks22.49%

Price Target Trends

1M3M12M
# Anlaysts1227
Avg Price Target$42.00$51.00$48.70
Last Closing Price$36.80$36.80$36.80
Upside/Downside14.13%38.59%32.34%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 266175--28
Apr, 266175--28
Mar, 266165--27
Feb, 265165--26
Jan, 2645---9
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 07, 2026Deutsche Bank$42.00$41.950.12%14.13%
Mar 09, 2026Ivan FeinsethTigress Financial$60.00$43.4138.22%63.04%
Feb 25, 2026Michael ChernyLeerink Partners$56.00$48.1816.23%52.17%
Feb 25, 2026Stifel Nicolaus$55.00$48.1814.16%49.46%
Feb 25, 2026Evercore ISI$55.00$49.3811.38%49.46%
Feb 05, 2026Tigress Financial$55.00$45.0122.20%49.46%
Jan 21, 2026David LarsenJ.P. Morgan$55.00$43.1727.40%49.46%
Jan 12, 2026Barclays$50.00$41.6520.05%35.87%
Jan 12, 2026BNP Paribas$38.00$42.19-9.93%3.26%
Jan 12, 2026Wolfe Research$47.00$41.8812.23%27.72%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 13, 2026Tigress FinancialBuyBuyhold
May 07, 2026CitigroupBuyBuyhold
Feb 25, 2026Evercore ISIOutperformOutperformhold
Feb 05, 2026Tigress FinancialBuyinitialise
Jan 21, 2026BTIGBuyBuyhold
Jan 12, 2026CitigroupBuyinitialise
Jan 12, 2026BarclaysOverweightinitialise
Jan 12, 2026Exane BNP ParibasNeutralinitialise
Jan 12, 2026Wolfe ResearchOutperforminitialise
Jan 12, 2026Deutsche BankHoldinitialise

Financial Forecast

EPS Forecast

Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$1.21$1.48
High Forecast$1.31$1.52
Low Forecast$1.18$1.42
Surprise %--

Revenue Forecast

$28B $28B $29B $30B $30B $31B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$28.14B$30.52B
High Forecast$28.18B$30.98B
Low Forecast$27.98B$30.15B
Surprise %--

Net Income Forecast

$900M $960M $1B $1B $1B $1B Dec 25 Dec 26
Dec 25Dec 26
Reported--
Avg Forecast$950.74M$1.16B
High Forecast$1.03B$1.20B
Low Forecast$928.80M$1.12B
Surprise %--

MDLN Forecast FAQ

Is Medline stock a buy?

Medline stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medline is a favorable investment for most analysts.

What is Medline's price target?

Medline's price target, set by 12 Wall Street analysts, averages $48.91 over the next 12 months. The price target range spans from $38 at the low end to $60 at the high end, suggesting a potential 32.91% change from the previous closing price of $36.8.

How does Medline stock forecast compare to its benchmarks?

Medline's stock forecast shows a 32.91% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (22.49%).

What is the breakdown of analyst ratings for Medline over the past three months?

  • May 2026: 21.43% Strong Buy, 60.71% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 21.43% Strong Buy, 60.71% Buy, 17.86% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 22.22% Strong Buy, 59.26% Buy, 18.52% Hold, 0% Sell, 0% Strong Sell.

What is Medline’s EPS forecast?

Medline's average annual EPS forecast for its fiscal year ending in December 2025 is $1.21, marking a 0% decrease from the reported - in 2024. Estimates for the following years are.

What is Medline’s revenue forecast?

Medline's average annual revenue forecast for its fiscal year ending in December 2025 is $28.14B, reflecting a 0% decrease from the reported - in 2024. The forecast for.

What is Medline’s net income forecast?

Medline's net income forecast for the fiscal year ending in December 2025 stands at $950.74M, representing a 0% decrease from the reported - in 2024. Projections indicate .